Reference health
Bioresorbable Scaffold
93/93 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
11 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 93 checked references that resolve
resolves10.1016/0002-8703(94)90675-0
Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty
resolves10.1056/NEJM198703193161201
Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty
resolves10.1016/S0735-1097(88)80046-9
Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 Patients
resolves10.1056/NEJM198704303161805
Long-Term Follow-up after Percutaneous Transluminal Coronary Angioplasty
resolves10.1093/oxfordjournals.eurheartj.a061852
Recurrence rate after successful coronary angioplasty
resolves10.1161/01.CIR.77.2.361
Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.
resolves10.1161/01.CIR.73.4.710
Restenosis after successful coronary angioplasty in patients with single-vessel disease.
resolves10.1161/01.CIR.96.2.475
Remodeling of Human Coronary Arteries Undergoing Coronary Angioplasty or Atherectomy
resolves10.1016/S0002-9149(99)80409-3
Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy
resolves10.1161/01.ATV.16.11.1393
Coronary Artery Restenosis After Balloon Angioplasty in Humans Is Associated With Circumferential Coronary Constriction
resolves10.1161/01.CIR.91.5.1397
Coronary Stenting Decreases Restenosis in Lesions With Early Loss in Luminal Diameter 24 Hours After Successful PTCA
resolves10.1016/S0735-1097(10)80111-1
Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients
resolves10.1016/S0735-1097(10)80113-5
Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: Analysis of tissue obtained from 73 patients by directional atherectomy
resolves10.1056/NEJM199408253310801
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
resolves10.1056/NEJM199408253310802
A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
resolves10.1161/01.CIR.103.2.192
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries
resolves10.1053/euhj.2001.2892
Coronary restenosis elimination with a sirolimus eluting stent; First European human experience with 6-month angiographic and intravascular ultrasonic follow-up
resolves10.1161/hc4201.098056
Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents
resolves10.1056/NEJMoa012843
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
resolves10.1016/j.jacc.2005.02.086
Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents
resolves10.1016/S0140-6736(04)17275-9
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
resolves10.1056/NEJMoa067722
Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden
resolves10.1016/j.jacc.2006.10.026
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
resolves10.1016/S0140-6736(07)60314-6
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
resolves10.1016/j.jacc.2008.07.006
Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice
resolves10.1016/j.jacc.2009.11.049
5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions
resolves10.1161/circulationaha.107.693739
Pathological Correlates of Late Drug-Eluting Stent Thrombosis
resolves10.1093/eurheartj/ehi571
Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation
resolves10.1016/j.jacc.2005.01.062
Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction
resolves10.1016/S0140-6736(09)60325-1
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
resolves10.1093/eurheartj/ehm194
Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach
resolves10.1056/NEJMoa0804626
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
resolves10.1161/01.cir.0000156462.97532.8f
Artifact-Free Coronary Magnetic Resonance Angiography and Coronary Vessel Wall Imaging in the Presence of a New, Metallic, Coronary Magnetic Resonance Imaging Stent
resolves10.1111/j.1540-8183.1992.tb00425.x
Development of a Polymer Endovascular Prosthesis and its Implantation in Porcine Arteries
resolves10.1161/01.CIR.94.7.1690
Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries
resolves10.1016/S0735-1097(96)00584-0
Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model
resolves10.1016/S0735-1097(98)00312-X
Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo
resolves10.4244/EIJV5IFA3
Design principles and performance of bioresorbable polymeric coronary scaffolds
resolves10.1016/0142-9612(81)90060-0
Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (ε-caprolactone), and their copolymers in vivo
resolves10.1016/0168-3659(87)90020-4
Modification of the rates of chain cleavage of poly(ϵ-caprolactone) and related polyesters in the solid state
resolves10.1002/app.1981.070261124
Aliphatic polyesters. I. The degradation of poly(ϵ‐caprolactone) <i>in vivo</i>
resolves10.1243/0954411041932809
Degradation of poly-L-lactide. Part 2: Increased temperature accelerated degradation
resolves10.1243/0954411041932782
Degradation of poly-L-lactide. Part 1:
<i>in vitro</i>
and
<i>in vivo</i>
physiological temperature degradation
resolves10.1002/jbm.a.31053
Modeling of degradation and drug release from a biodegradable stent coating
resolves10.1161/circulationaha.109.921528
Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model
resolves10.1161/01.CIR.102.4.399
Initial and 6-Month Results of Biodegradable Poly-
<i>l</i>
-Lactic Acid Coronary Stents in Humans
resolves10.1159/000159144
Thrombogenicity of the Human Arterial Wall after Interventional Thermal Injury
resolves10.1016/S0140-6736(07)60853-8
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial
resolves10.1136/heart.89.6.651
Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?
resolves10.1002/ccd.20727
Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries
resolves10.1583/04-1349R.1
Preliminary Results After Application of Absorbable Metal Stents in Patients With Critical Limb Ischemia
resolves10.1016/j.jcin.2008.09.015
Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries
resolves10.4244/JV4I4A82
Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents
resolves10.1007/s00270-008-9472-8
AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis
resolves10.1002/ccd.21607
Novel bioabsorbable salicylate‐based polymer as a drug‐eluting stent coating
resolves10.1016/S0140-6736(08)60415-8
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
resolves10.4244/EIJV4I2A49
Quantitative multi-modality imaging analysis of a bioabsorbable poly-L-lactic acid stent design in the acute phase: a comparison between 2- and 3D-QCA, QCU and QMSCT-CA
resolves10.1161/01.cir.0000097067.96619.1f
Characterizing Vulnerable Plaque Features With Intravascular Elastography
resolves10.1161/01.cir.0000131887.65955.3b
Incidence of High-Strain Patterns in Human Coronary Arteries
resolves10.1002/ccd.21310
Three‐dimensional and quantitative analysis of atherosclerotic plaque composition by automated differential echogenicity
resolves10.4244/EIJV4I4A77
Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis A substudy of the ABSORB clinical trial
resolves10.1016/j.jacc.2006.09.047
Selective Clearance of Macrophages in Atherosclerotic Plaques by Autophagy
resolves10.4244/EIJ30V6I4A76
Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial
resolves10.1002/ccd.21136
Comparison of in vivo acute stent recoil between the bioabsorbable everolimus‐eluting coronary stent and the everolimus‐eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials
resolves10.1016/j.jacc.2008.08.024
Late Stent Recoil of the Bioabsorbable Everolimus-Eluting Coronary Stent and its Relationship With Plaque Morphology
resolves10.4244/EIJV5I8A157
In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial
resolves10.1161/circulationaha.110.970772
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis
resolves10.1016/j.jcin.2009.10.004
The First-Generation Drug-Eluting Stents and Coronary Endothelial Dysfunction
resolves10.1161/01.CIR.0000025404.78001.D8
Prognostic Value of Coronary Vascular Endothelial Dysfunction
resolves10.1161/01.CIR.101.9.948
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
resolves10.1016/S0735-1097(99)00073-X
Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and caucasian patients
resolves10.1056/NEJM199306103282302
Evidence of Impaired Endothelium-Dependent Coronary Vasodilatation in Patients with Angina Pectoris and Normal Coronary Angiograms
resolves10.1161/01.CIR.85.5.1899
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.
resolves10.1093/oxfordjournals.eurheartj.a059557
A comparison of two methods to measure coronary flow reserve in the setting of coronary angioplasty: intracoronary blood flow velocity measurements with a Doppler catheter, and digital subtraction cineangiography
resolves10.1016/S0140-6736(07)61444-5
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
The 11 references without a DOI — listed, not checked
no DOI — not checkedClowes AW, Reidy MA, Clowes MM . Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983; 49: 327– 333.
no DOI — not checkedPlastics guide for vocabulary in the field of degradable and biodegradable polymers and plastic items. 2006. CEN/Tech. Rep. 15351.
no DOI — not checkedEnglish JP, Perrin DE . Polyglycolide and polylactide. In: , Wiseman DM, Kost J, Domb AJ eds. Handbook of Biodegradable Polymers. Boca Raton, FL: CRC Press; 1998.
no DOI — not checkedHollinger JO, Battistone GC . Biodegradable bone repair materials: synthetic polymers and ceramics. Clin Orthop Relat Res. 1986; 290– 305.
no DOI — not checkedGarg S, Serruys P . Biodegradable stents and non-biodegradable stents. Minerva Cardioangiol. 2009; 57: 537– 565.
no DOI — not checkedTsuji T, Tamai H, Igaki K, Hsu Y-S, Kosuga K, Hata T, Okada M, Nakamura T, Fujita S . Four-year follow-up of the biodegradable stent (Igaki-Tamai stent). Circ J. 2004; 68: 135.
no DOI — not checkedNishio S . Long-term (>10 years) clinical outcomes of first-in-man biodegradable poly-l-lactic acid coronary stents. Eurointervenion. 2010; 6: H44.
no DOI — not checkedBiamino G, Schmidt A, Scheinert D . Treatment of SFA lesions with PLLA biodegradable stents: results of the PERSEUS Study. J Endovasc Ther. 2005; 12: 5.
no DOI — not checkedSchulze R . REVA Medical, Inc. Bioresorbable stent. Presented at: Cardiovascular Revascularization Therapies Conference; March 7–9, 2007; Washington, DC.
no DOI — not checkedSchultz R . REVA medical, inc. Bioresorbable technology. Presented at: Cardiovascular Revascularization Therapies Conference; April 3–6, 2006; Washington, DC.
no DOI — not checkedGrube E . Bioabsorbable stent: the Boston Scientific and REVA technology. Presented at: EuroPCR; May 19–22, 2009; Barcelona, Spain.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1161/circulationaha.110.971606"><img src="https://citestamp.com/citestamped/10.1161/circulationaha.110.971606/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1161/circulationaha.110.971606)